Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Chest ; 166(3): e79-e82, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39260950

RESUMO

CASE PRESENTATION: A 74-year-old woman with a history of hypertension and peripheral artery disease and a reported diagnosis of sarcoidosis presents for an episode of syncope and shortness of breath. She had a history of sarcoidosis diagnosed on chest radiography that showed lymphadenopathy. There were no associated symptoms, and she was not previously treated for sarcoidosis. She previously smoked and had quit smoking 9 years earlier.


Assuntos
Síncope , Humanos , Feminino , Idoso , Síncope/etiologia , Síncope/diagnóstico , Sarcoidose/complicações , Sarcoidose/diagnóstico , Diagnóstico Diferencial , Tomografia Computadorizada por Raios X
2.
Tex Heart Inst J ; 48(5)2021 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-34913970

RESUMO

Atypical presentations of ST-segment-elevation myocardial infarction (STEMI) have been reported in patients who have COVID-19. We have seen this occurrence in our center in Bronx, New York, where multitudes of patients sought treatment for the coronavirus. We studied the prevalence of atypical STEMI findings among patients with COVID-19 who presented during the first 2 months of the pandemic. Consistent with previous reports, 4 of our 10 patients with COVID-19 and STEMI had no identifiable culprit coronary lesion; rather, they often had diffuse ST-segment elevations on surface electrocardiograms along with higher levels of D-dimer and inflammatory markers. In contrast, 32 of 33 patients without COVID-19 (97%) had a culprit lesion. The patients with COVID-19 and a culprit lesion more often needed thrombectomy catheterization and administration of glycoprotein IIb/IIIa inhibitors. Our study confirms that patients with COVID-19 often have atypical STEMI presentations, including the frequent absence of a culprit coronary lesion. Our findings can help clinicians prepare for these atypical clinical presentations.


Assuntos
COVID-19 , Infarto do Miocárdio com Supradesnível do Segmento ST , Humanos , Cidade de Nova Iorque/epidemiologia , Pandemias , SARS-CoV-2 , Infarto do Miocárdio com Supradesnível do Segmento ST/diagnóstico , Infarto do Miocárdio com Supradesnível do Segmento ST/epidemiologia , Infarto do Miocárdio com Supradesnível do Segmento ST/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA